We find that HPV vaccine clinical trials design, and data interpretation of both efficacy and safety outcomes, were largely inadequate.
Likewise, the notion that HPV vaccines have an impressive safety profile is only supported by highly flawed design of safety trials and is contrary to accumulating evidence from vaccine safety surveillance databases and case reports which continue to link HPV vaccination to serious adverse outcomes (including death and permanent disabilities).
We thus conclude that further reduction of cervical cancers might be best achieved by optimizing cervical screening (which carries no such risks) and targeting other factors of the disease rather than by the reliance on vaccines with questionable efficacy and safety profiles." It is truly mindboggling, and a true testament to the conflicts of interest manipulating public health guidelines, that the HPV vaccine has received such robust backing by health officials and legislators alike.
Back in 2007, just a year after Gardasil's introduction to the market, Texas Governor Rick Perry went so far as signing an executive order mandating sixth-grade girls to be vaccinated against HPV.
There are currently two HPV vaccines on the market, but if there was any regard for sound scientific evidence, neither would be promoted as heavily as they are.
The first, Gardasil, was licensed by the US Food and Drug Administration (FDA) in 2006.
It is now recommended as a routine vaccination for girls and women between the ages of 9-26 in the US.On October 25, 2011, the CDC's Advisory Committee on Immunization Practices also voted to recommend giving the HPV vaccine to males between the ages of 11 and 21.The second HPV vaccine, Cervarix, was licensed in 2009.Were it to be discovered that the HPV vaccine, in fact, does not effectively prevent cancer, then young women (and now boys) are being exposed to clearly unacceptable health risks.And that's precisely what a recent study has concluded...a systematic review of pre- and post-licensure trials of the HPV vaccine by a Canadian team shows that its effectiveness is not only overstated (through the use of selective reporting or "cherry picking" data) but also completely "We carried out a systematic review of HPV vaccine pre- and post-licensure trials to assess the evidence of their effectiveness and safety.